This annual international press-monitored congress features a highly relevant seminar lineup that emphasize the most current developments, collaborations, challenges and opportunities for the Swedish and Danish life science sectors, pre-bookable one-to-one partnering sessions, exceptional networking prospects, and a vibrant exhibition showcasing the offerings of many prominent industry stakeholders.
These fundamental components run in parallel, ensuring attendees immerse in a dynamic, full-day experience aimed at igniting inspiration, disseminating insights, and fostering pivotal partnerships. Annually, the event draws more than 500 decision-makers from around the world, spanning pharma, biotech, and medtech industries, as well as academic research, healthcare, policy makers, regulatory bodies, and the financial services sector.
Register and save the date and then C U for the opening keynote “How can we sustain and accelerate life science investments in the Nordics” with Darine Ghanem, General Manager Denmark, Roche Pharmaceuticals followed by an inspiring funding session with among others Lene Oddershede, Senior Vice President Nat-Tech, Novo Nordisk Foundation, Charlotte Nørgaard Langer, Women’s Health Lead, Angella Invest, Peter Horn Møller, Founder and CBO, Marigold Innovation and Sanne Brun Jensen, Senior Associate, BioInnovation Institute.
See the full programme moderated by Nina Rawal, Partner and Co-Head, Trill Impact Ventures
Date: 29 August, 2024
Time: 9.00
Venue: Medicon Village, Scheelevägen 4, 223 63 Lund
Price: SEK 799 + VAT (25%) for non-members
Free of charge for members of Life Science Sweden, Medicon Valley Alliance, Medicon Village, and event partners.